<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36902042</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Synaptic Dysfunction and Plasticity in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4613</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24054613</ELocationID><Abstract><AbstractText>Recent evidence has supported the hypothesis that amyotrophic lateral sclerosis (ALS) is a multi-step disease, as the onset of symptoms occurs after sequential exposure to a defined number of risk factors. Despite the lack of precise identification of these disease determinants, it is known that genetic mutations may contribute to one or more of the steps leading to ALS onset, the remaining being linked to environmental factors and lifestyle. It also appears evident that compensatory plastic changes taking place at all levels of the nervous system during ALS etiopathogenesis may likely counteract the functional effects of neurodegeneration and affect the timing of disease onset and progression. Functional and structural events of synaptic plasticity probably represent the main mechanisms underlying this adaptive capability, causing a significant, although partial and transient, resiliency of the nervous system affected by a neurodegenerative disease. On the other hand, the failure of synaptic functions and plasticity may be part of the pathological process. The aim of this review was to summarize what it is known today about the controversial involvement of synapses in ALS etiopathogenesis, and an analysis of the literature, although not exhaustive, confirmed that synaptic dysfunction is an early pathogenetic process in ALS. Moreover, it appears that adequate modulation of structural and functional synaptic plasticity may likely support function sparing and delay disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gulino</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8067-697X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, Physiology Section, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS pathogenesis</Keyword><Keyword MajorTopicYN="N">compensatory mechanisms</Keyword><Keyword MajorTopicYN="N">disease onset</Keyword><Keyword MajorTopicYN="N">homeostatic synaptic plasticity</Keyword><Keyword MajorTopicYN="N">motoneuron disease</Keyword><Keyword MajorTopicYN="N">structural plasticity</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36902042</ArticleId><ArticleId IdType="pmc">PMC10003601</ArticleId><ArticleId IdType="doi">10.3390/ijms24054613</ArticleId><ArticleId IdType="pii">ijms24054613</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gordon P.H. Amyotrophic lateral sclerosis: An update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 2013;4:295&#x2013;310. doi: 10.14336/AD.2013.0400295.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2013.0400295</ArticleId><ArticleId IdType="pmc">PMC3794725</ArticleId><ArticleId IdType="pubmed">24124634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G., Eurals Consortium Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirola L., Mukherjee A., Mutsuddi M. Recent updates on the genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Mol. Neurol. 2022;59:5673&#x2013;5694. doi: 10.1007/s12035-022-02934-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02934-z</ArticleId><ArticleId IdType="pubmed">35768750</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas C., Manzano R., Vaz R., Osta R., Brites D. Synaptic failure: Focus in an integrative view of ALS. Brain Plast. 2016;1:159&#x2013;175. doi: 10.3233/BPL-140001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BPL-140001</ArticleId><ArticleId IdType="pmc">PMC5928542</ArticleId><ArticleId IdType="pubmed">29765840</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chi&#xf2; A., de Carvalho M., Ince P.G., Lin C., Miller R.G., Mitsumoto H., et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:459&#x2013;470. doi: 10.1002/mus.10191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10191</ArticleId><ArticleId IdType="pubmed">12362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918&#x2013;934. doi: 10.1016/j.cell.2010.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.02.016</ArticleId><ArticleId IdType="pmc">PMC2873093</ArticleId><ArticleId IdType="pubmed">20303880</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chi&#xf2; A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 2017;3:17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>St Martin J.L., Wang L., Kaprielian Z. Toxicity in ALS: TDP-43 modifiers and C9orf72. Neurosci. Lett. 2020;716:134621. doi: 10.1016/j.neulet.2019.134621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134621</ArticleId><ArticleId IdType="pubmed">31726180</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio F., Maduro C., Fisher E.M.C., Acevedo-Arozena A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis. Model. Mech. 2019;12:dmm037424. doi: 10.1242/dmm.037424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.037424</ArticleId><ArticleId IdType="pmc">PMC6361152</ArticleId><ArticleId IdType="pubmed">30626575</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Rodent models of amyotrophic lateral sclerosis. Curr. Protoc. Pharmacol. 2015;69:5.67.1&#x2013;5.67.21. doi: 10.1002/0471141755.ph0567s69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0567s69</ArticleId><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Calvo A., Chi&#xf2; A., Colville S., Ellis C.M., Hardiman O., Heverin M., Howard R.S., Huisman M.H.B., Keren N., et al. Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study. Lancet Neurol. 2014;13:1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mazzini L., D&#x2019;Alfonso S., Corrado L., Canosa A., Moglia C., Manera U., Bersano E., Brunetti M., Barberis M., et al. The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology. 2018;91:e635&#x2013;e642. doi: 10.1212/WNL.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciuro M., Sangiorgio M., Leanza G., Gulino R. A meta-analysis study of SOD1-mutant mouse models of ALS to analyse the determinants of disease onset and progression. Int. J. Mol. Sci. 2022;24:216. doi: 10.3390/ijms24010216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010216</ArticleId><ArticleId IdType="pmc">PMC9820332</ArticleId><ArticleId IdType="pubmed">36613659</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., van den Berg L.H., Veldink J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Bonetto V., Pupillo E., Logroscino G., Al-Chalabi A., Lunetta C., Riva N., Mora G., Lauria G., Weishaupt J.H., et al. Focus on the heterogeneity of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2020;21:485&#x2013;495. doi: 10.1080/21678421.2020.1779298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1779298</ArticleId><ArticleId IdType="pubmed">32583689</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S., Kollewe K., Fahlbusch M., Zapf A., Dengler R., Krampfl K., Petri S. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve. 2011;43:636&#x2013;642. doi: 10.1002/mus.21936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21936</ArticleId><ArticleId IdType="pubmed">21484822</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanouchi T., Takuya O., Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J. Neurol. Neurosurg. Psychiatry. 2012;83:739&#x2013;745. doi: 10.1136/jnnp-2011-301826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301826</ArticleId><ArticleId IdType="pmc">PMC3368493</ArticleId><ArticleId IdType="pubmed">22544947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J.M., La Spada A.R. ALS motor phenotype heterogeneity, focality, and spread. Neurology. 2009;73:805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott L.F., Nelson S.B. Synaptic plasticity. taming the beast. Nat. Neurosci. 2000;3((Suppl. 11)):1178&#x2013;1183. doi: 10.1038/81453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/81453</ArticleId><ArticleId IdType="pubmed">11127835</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Park E., Zhong L.R., Chen L. Homeostatic synaptic plasticity as a metaplasticity mechanism&#x2014;A molecular and cellular perspective. Curr. Opin. Neurobiol. 2019;54:44&#x2013;53. doi: 10.1016/j.conb.2018.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2018.08.010</ArticleId><ArticleId IdType="pmc">PMC6361678</ArticleId><ArticleId IdType="pubmed">30212714</ArticleId></ArticleIdList></Reference><Reference><Citation>Tononi G., Cirelli C. Sleep and the price of plasticity: From synaptic and cellular homeostasis to memory consolidation and integration. Neuron. 2014;81:12&#x2013;34. doi: 10.1016/j.neuron.2013.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.025</ArticleId><ArticleId IdType="pmc">PMC3921176</ArticleId><ArticleId IdType="pubmed">24411729</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrigiano G. Homeostatic synaptic plasticity: Local and global mechanisms for stabilizing neuronal function. Cold Spring Harb. Perspect. Biol. 2012;4:a005736. doi: 10.1101/cshperspect.a005736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a005736</ArticleId><ArticleId IdType="pmc">PMC3249629</ArticleId><ArticleId IdType="pubmed">22086977</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Berhardi R., Eugen&#xed;n-von Bernhardi L., Eugen&#xed;n J. What is neural plasticity? Adv. Exp. Med. Biol. 2017;1015:1&#x2013;15. doi: 10.1007/978-3-319-62817-2_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-62817-2_1</ArticleId><ArticleId IdType="pubmed">29080018</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcea I., Froemke R.C. Cortical plasticity, excitatory-inhibitory balance, and sensory perception. Prog. Brain Res. 2013;207:65&#x2013;90. doi: 10.1016/B978-0-444-63327-9.00003-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63327-9.00003-5</ArticleId><ArticleId IdType="pmc">PMC4300113</ArticleId><ArticleId IdType="pubmed">24309251</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis G.W. Homeostatic control of neural activity: From phenomenology to molecular design. Annu. Rev. Neurosci. 2006;29:307&#x2013;323. doi: 10.1146/annurev.neuro.28.061604.135751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.28.061604.135751</ArticleId><ArticleId IdType="pubmed">16776588</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrigiano G. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu. Rev. Neurosci. 2011;34:89&#x2013;103. doi: 10.1146/annurev-neuro-060909-153238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-060909-153238</ArticleId><ArticleId IdType="pubmed">21438687</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauth M., Tetzlaff C. Opposing effects of neuronal activity on structural plasticity. Front. Neuroanat. 2016;10:75. doi: 10.3389/fnana.2016.00075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2016.00075</ArticleId><ArticleId IdType="pmc">PMC4923203</ArticleId><ArticleId IdType="pubmed">27445713</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati S.S., Garrett T., Elbasiouny S.M. The vulnerability of spinal motoneurons and soma size plasticity in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 2018;596:1723&#x2013;1745. doi: 10.1113/JP275498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP275498</ArticleId><ArticleId IdType="pmc">PMC5924829</ArticleId><ArticleId IdType="pubmed">29502344</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand J., Amendola J., Bories C., Lamotte d&#x2019;Incamps B. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis. J. Physiol. Paris. 2006;99:211&#x2013;220. doi: 10.1016/j.jphysparis.2005.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphysparis.2005.12.014</ArticleId><ArticleId IdType="pubmed">16448809</ArticleId></ArticleIdList></Reference><Reference><Citation>Giusto E., Codrich M., de Leo G., Francardo V., Coradazzi M., Parenti R., Gulisano M., Vicario N., Gulino R., Leanza G. Compensatory changes in degenerating spinal motoneurons sustain functional sparing in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 2020;528:231&#x2013;243. doi: 10.1002/cne.24751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24751</ArticleId><ArticleId IdType="pubmed">31364764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Vicario N., Giunta M.A.S., Spoto G., Calabrese G., Vecchio M., Gulisano M., Leanza G., Parenti R. Neuromuscular plasticity in a mouse model of spinal motoneuronal loss. Int. J. Mol. Sci. 2019;20:1500. doi: 10.3390/ijms20061500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061500</ArticleId><ArticleId IdType="pmc">PMC6471664</ArticleId><ArticleId IdType="pubmed">30917493</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Forte S., Parenti R., Gulisano M. TDP-43 as a modulator of synaptic plasticity in a mouse model of spinal motoneuron degeneration. CNS Neurol. Disord. Drug Targets. 2015;14:55&#x2013;60. doi: 10.2174/1871527314666150116115414.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527314666150116115414</ArticleId><ArticleId IdType="pubmed">25613499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Perciavalle V., Gulisano M. Expression of cell-fate determinants and plastic changes after neurotoxic lesion of adult mice spinal cord by cholera toxin-B saporin. Eur. J. Neurosci. 2010;31:1423&#x2013;1434. doi: 10.1111/j.1460-9568.2010.07170.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2010.07170.x</ArticleId><ArticleId IdType="pubmed">20384775</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicario N., Spitale F.M., Tibullo D., Giallongo C., Amorini A.M., Scandura G., Spoto G., Saab M.W., D&#x2019;Aprile S., Alberghina C., et al. Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing. Cell Death Dis. 2021;12:625. doi: 10.1038/s41419-021-03907-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03907-1</ArticleId><ArticleId IdType="pmc">PMC8209072</ArticleId><ArticleId IdType="pubmed">34135312</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor H.B.C., Jeans A.F. Friend or foe? The varied faces of homeostatic synaptic plasticity in neurodegenerative disease. Front. Cell. Neurosci. 2021;15:782768. doi: 10.3389/fncel.2021.782768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.782768</ArticleId><ArticleId IdType="pmc">PMC8702499</ArticleId><ArticleId IdType="pubmed">34955753</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra A., Galdi P., Pesce E., Fratello M., Trojsi F., Tedeschi G., Tagliaferri R., Esposito F. Strong-weak pruning for brain network identification in connectome-wide neuroimaging: Application to amyotrophic lateral sclerosis disease stage characterization. Int. J. Neural. Syst. 2019;29:1950007. doi: 10.1142/S0129065719500072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0129065719500072</ArticleId><ArticleId IdType="pubmed">30929575</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins E.M., Burr K., Banerjee P., Mehta A.R., Dando O., Selvaraj B.T., Suminaite D., Nanda J., Henstridge C.M., Gillingwater T.H., et al. Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction. Mol. Neurodegener. 2021;16:13. doi: 10.1186/s13024-021-00433-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00433-8</ArticleId><ArticleId IdType="pmc">PMC7931347</ArticleId><ArticleId IdType="pubmed">33663561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarevic V., Yang Y., Ivanova D., Fejtova A., Svenningsson P. Riluzole attenuates the efficacy of glutamatergic transmission by interfering with the size of the readily releasable neurotransmitter pool. Neuropharmacology. 2018;143:38&#x2013;48. doi: 10.1016/j.neuropharm.2018.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.09.021</ArticleId><ArticleId IdType="pubmed">30222983</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Valsasina P., Absinta M., Riva N., Sala S., Prelle A., Copetti M., Comola M., Comi G., Filippi M. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb. Cortex. 2011;21:2291&#x2013;2298. doi: 10.1093/cercor/bhr002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhr002</ArticleId><ArticleId IdType="pubmed">21368084</ArticleId></ArticleIdList></Reference><Reference><Citation>Poujois A., Schneider F.C., Faillenot I., Camdessanch&#xe9; J.-P., Vandenberghe N., Thomas-Ant&#xe9;rion C., Antoine J.-C. Brain plasticity in the motor network is correlated with disease progression in amyotrophic lateral sclerosis. Hum. Brain Mapp. 2013;34:2391&#x2013;2401. doi: 10.1002/hbm.22070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22070</ArticleId><ArticleId IdType="pmc">PMC6870334</ArticleId><ArticleId IdType="pubmed">22461315</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller J., B&#xf6;hm S., Aho-&#xd6;zhan H.E.A., Loose M., Gorges M., Kassubek J., Uttner I., Abrahams S., Ludolph A.C., Lul&#xe9; D. Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis. Brain Imaging Behav. 2018;12:771&#x2013;784. doi: 10.1007/s11682-017-9738-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-017-9738-3</ArticleId><ArticleId IdType="pubmed">28600740</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C., Jansen A., Henningsen H., Sommer J., Turski P.A., Brooks B.R., Knecht S. Subcortical reorganization in amyotrophic lateral sclerosis. Exp. Brain Res. 2006;172:361&#x2013;369. doi: 10.1007/s00221-006-0352-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-006-0352-7</ArticleId><ArticleId IdType="pubmed">16463149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D., Diekmann V., Kassubek J., Kurt A., Birbaumer N., Ludolph A.C., Kraft E. Cortical plasticity in amyotrophic lateral sclerosis: Motor imagery and function. Neurorehabil. Neural Repair. 2007;21:518&#x2013;526. doi: 10.1177/1545968307300698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968307300698</ArticleId><ArticleId IdType="pubmed">17476000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi B., Kollewe K., Samii A., Dengler R., M&#xfc;nte T.F. Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. Hum. Brain Mapp. 2011;32:750&#x2013;758. doi: 10.1002/hbm.21064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.21064</ArticleId><ArticleId IdType="pmc">PMC6870014</ArticleId><ArticleId IdType="pubmed">20836159</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalloni A., Origlia N., Sgobio C., Trabalza A., Nutini M., Berretta N., Bernardi G., Domenici L., Ammassari-Teule M., Longone P. Postsynaptic alteration of NR2A subunit and defective autophosphorylation of alphaCaMKII at threonine-286 contribute to abnormal plasticity and morphology of upper motor neurons in presymptomatic SOD1G93A mice, a murine model for amyotrophic lateral sclerosis. Cereb. Cortex. 2011;21:796&#x2013;805. doi: 10.1093/cercor/bhq152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhq152</ArticleId><ArticleId IdType="pubmed">20732897</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoen M., Reichel J.M., Demestre M., Putz S., Deshpande D., Proepper C., Liebau S., Schmeisser M.J., Ludolph A.C., Michaelis J., et al. Super-resolution microscopy reveals presynaptic localization of the ALS/FTD related protein FUS in hippocampal neurons. Front. Cell. Neurosci. 2016;9:496. doi: 10.3389/fncel.2015.00496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00496</ArticleId><ArticleId IdType="pmc">PMC4709451</ArticleId><ArticleId IdType="pubmed">26834559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.Y., Agrawal I., Tyan S.-H., Sanford E., Chang W.-T., Lim K., Ong J., Tan B.S.Y., Moe A.A.K., Yu R., et al. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits. Acta Neuropathol. Commun. 2021;9:9. doi: 10.1186/s40478-020-01111-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01111-4</ArticleId><ArticleId IdType="pmc">PMC7789430</ArticleId><ArticleId IdType="pubmed">33407930</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J.N., Artates J., Bui A.T., Vetto A.P., et al. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018;100:816&#x2013;830.e7. doi: 10.1016/j.neuron.2018.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahadevan S., Hembach K.M., Tantardini E., P&#xe9;rez-Berlanga M., Hruska-Plochan M., Megat S., Weber J., Schwarz P., Dupuis L., Robinson M.D., et al. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS. Nat. Commun. 2021;12:3027. doi: 10.1038/s41467-021-23188-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23188-8</ArticleId><ArticleId IdType="pmc">PMC8140117</ArticleId><ArticleId IdType="pubmed">34021139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Hughes E.G., Shetty A.S., Arlotta P., Goff L.A., Bergles D.E., Brown S.P. Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J. Neurosci. 2017;37:9037&#x2013;9053. doi: 10.1523/JNEUROSCI.0811-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0811-17.2017</ArticleId><ArticleId IdType="pmc">PMC5597984</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C.-E., Jin L.-W., Chu Y.-P., Wei W.-Y., Ho P.-C., Tsai K.J. TDP-43 proteinopathy impairs mRNP granule mediated postsynaptic translation and mRNA metabolism. Theranostics. 2021;11:330&#x2013;345. doi: 10.7150/thno.51004.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.51004</ArticleId><ArticleId IdType="pmc">PMC7681104</ArticleId><ArticleId IdType="pubmed">33391478</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley E.E., Reale L.A., Chuckowree J.A., Dyer M.S., Barnett G.L., Clark C.M., Bennett W., Dickson T.C., Blizzard C.A. Estrogen enhances dendrite spine function and recovers deficits in neuroplasticity in the prpTDP-43A315T mouse model of amyotrophic lateral sclerosis. Mol. Neurobiol. 2022;59:2962&#x2013;2976. doi: 10.1007/s12035-022-02742-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02742-5</ArticleId><ArticleId IdType="pmc">PMC9016039</ArticleId><ArticleId IdType="pubmed">35249200</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Woo J.-A.A., Bukhari M.Z., Wang X., Yan Y., Cazzaro Buosi S., Ermekbaeva A., Sista A., Kotsiviras P., LePochat P., et al. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10. Acta Neuropathol. Commun. 2022;10:95. doi: 10.1186/s40478-022-01386-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01386-9</ArticleId><ArticleId IdType="pmc">PMC9254494</ArticleId><ArticleId IdType="pubmed">35787294</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K.-J., Yang C.-H., Fang Y.-H., Cho K.-H., Chien W.-L., Wang W.-T., Wu T.-W., Lin C.-P., Fu W.-M., Shen C.-K.J. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J. Exp. Med. 2010;207:1661&#x2013;1673. doi: 10.1084/jem.20092164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20092164</ArticleId><ArticleId IdType="pmc">PMC2916125</ArticleId><ArticleId IdType="pubmed">20660618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L.-S., Cheng W.-C., Chen C.-Y., Wu M.-C., Wang Y.-C., Tseng Y.-H., Chuang T.-J., Shen C.-K.J. Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons. Acta Neuropathol. Commun. 2019;7:50. doi: 10.1186/s40478-019-0674-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0674-x</ArticleId><ArticleId IdType="pmc">PMC6440020</ArticleId><ArticleId IdType="pubmed">30922385</ArticleId></ArticleIdList></Reference><Reference><Citation>Terreros-Roncal J., Moreno-Jim&#xe9;nez E.P., Flor-Garc&#xed;a M., Rodr&#xed;guez-Moreno C.B., Trinchero M.F., Cafini F., R&#xe1;bano A., Llorens-Mart&#xed;n M. Impact of neurodegenerative diseases on human adult hippocampal neurogenesis. Science. 2021;374:1106&#x2013;1113. doi: 10.1126/science.abl5163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl5163</ArticleId><ArticleId IdType="pmc">PMC7613437</ArticleId><ArticleId IdType="pubmed">34672693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.Y., Navakkode S., Liu F., Soong T.W., Ling S.-C. Deregulated expression of a longevity gene, Klotho, in the C9orf72 deletion mice with impaired synaptic plasticity and adult hippocampal neurogenesis. Acta Neuropathol. Commun. 2020;8:155. doi: 10.1186/s40478-020-01030-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01030-4</ArticleId><ArticleId IdType="pmc">PMC7473815</ArticleId><ArticleId IdType="pubmed">32887666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer C.S., Cohen R.N., Sironi F., Livesey M.R., Gillingwater T.H., Highley J.R., Fillingham D.J., Coldicott I., Smith E.F., Gibson Y.B., et al. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD. Acta Neuropathol. 2022;144:437&#x2013;464. doi: 10.1007/s00401-022-02470-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02470-z</ArticleId><ArticleId IdType="pmc">PMC9381633</ArticleId><ArticleId IdType="pubmed">35876881</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., McKeever P.M., Lau A., Robertson J. Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels. Acta Neuropathol. Commun. 2019;7:161. doi: 10.1186/s40478-019-0812-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0812-5</ArticleId><ArticleId IdType="pmc">PMC6813971</ArticleId><ArticleId IdType="pubmed">31651360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakthavachalu B., Huelsmeier J., Sudhakaran I.P., Hillebrand J., Singh A., Petrauskas A., Thiagarajan D., Sankaranarayanan M., Mizoue L., Anderson E.N., et al. RNP-granule assembly via Ataxin-2 disordered domains is required for long-term memory and neurodegeneration. Neuron. 2018;98:754&#x2013;766.e4. doi: 10.1016/j.neuron.2018.04.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.04.032</ArticleId><ArticleId IdType="pubmed">29772202</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasetto L., Grassano M., Pozzi S., Luotti S., Sammali E., Migazzi A., Basso M., Spagnolli G., Biasini E., Micotti E., et al. Defective cyclophilin A induces TDP-43 proteinopathy: Implications for amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2021;144:3710&#x2013;3726. doi: 10.1093/brain/awab333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab333</ArticleId><ArticleId IdType="pmc">PMC8719849</ArticleId><ArticleId IdType="pubmed">34972208</ArticleId></ArticleIdList></Reference><Reference><Citation>Koza P., Beroun A., Konopka A., G&#xf3;rkiewicz T., Bijoch L., Torres J.C., Bulska E., Knapska E., Kaczmarek L., Konopka W. Neuronal TDP-43 depletion affects activity-dependent plasticity. Neurobiol. Dis. 2019;130:104499. doi: 10.1016/j.nbd.2019.104499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104499</ArticleId><ArticleId IdType="pubmed">31176717</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalloni A., Geracitano R., Berretta N., Sgobio C., Bernardi G., Mercuri N.B., Longone P., Ammassari-Teule M. Molecular and synaptic changes in the hippocampus underlying superior spatial abilities in pre-symptomatic G93A+/+ mice overexpressing the human Cu/Zn superoxide dismutase (Gly93 --&gt; ALA) mutation. Exp. Neurol. 2006;197:505&#x2013;514. doi: 10.1016/j.expneurol.2005.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.10.014</ArticleId><ArticleId IdType="pubmed">16309674</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarta E., Fulgenzi G., Bravi R., Cohen E.J., Yanpallewar S., Tessarollo L., Minciacchi D. Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice. Mol. Cell. Neurosci. 2018;89:33&#x2013;41. doi: 10.1016/j.mcn.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.03.010</ArticleId><ArticleId IdType="pmc">PMC8108068</ArticleId><ArticleId IdType="pubmed">29580900</ArticleId></ArticleIdList></Reference><Reference><Citation>Rei N., Rombo D.M., Ferreira M.F., Baqi Y., M&#xfc;ller C.E., Ribeiro J.A., Sebasti&#xe3;o A.M., Vaz S.H. Hippocampal synaptic dysfunction in the SOD1G93A mouse model of Amyotrophic Lateral Sclerosis: Reversal by adenosine A2AR blockade. Neuropharmacology. 2020;171:108106. doi: 10.1016/j.neuropharm.2020.108106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2020.108106</ArticleId><ArticleId IdType="pubmed">32311420</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zyurt M.G., Topkara B., &#x130;&#x15f;ak B., T&#xfc;rker K.S. Amyotrophic lateral sclerosis weakens spinal recurrent inhibition and post-activation depression. Clin. Neurophysiol. 2020;131:2875&#x2013;2886. doi: 10.1016/j.clinph.2020.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.09.021</ArticleId><ArticleId IdType="pubmed">33157474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Maruyama S. Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis. Acta Neuropathol. 1994;88:222&#x2013;227. doi: 10.1007/BF00293397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00293397</ArticleId><ArticleId IdType="pubmed">7810293</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-S&#xe1;nchez F.F., Moral A., Rossi M.L., Quint&#xf3; L., Castej&#xf3;n C., Tolosa E., de Belleroche J. Synaptophysin in spinal anterior horn in aging and ALS: An immunohistological study. J. Neural Transm. 1996;103:1317&#x2013;1329. doi: 10.1007/BF01271192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01271192</ArticleId><ArticleId IdType="pubmed">9013418</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M.C., Adimula A., Birch D., Heckman C.J. Hyperexcitability in synaptic and firing activities of spinal motoneurons in an adult mouse model of amyotrophic lateral sclerosis. Neuroscience. 2017;362:33&#x2013;46. doi: 10.1016/j.neuroscience.2017.08.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.08.041</ArticleId><ArticleId IdType="pmc">PMC5614896</ArticleId><ArticleId IdType="pubmed">28844763</ArticleId></ArticleIdList></Reference><Reference><Citation>Herron L.R., Miles G.B. Gender-specific perturbations in modulatory inputs to motoneurons in a mouse model of amyotrophic lateral sclerosis. Neuroscience. 2012;226:313&#x2013;323. doi: 10.1016/j.neuroscience.2012.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.09.031</ArticleId><ArticleId IdType="pubmed">23000617</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen A.H., Athanasiou D. Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur. J. Neurosci. 2009;29:551&#x2013;561. doi: 10.1111/j.1460-9568.2008.06602.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06602.x</ArticleId><ArticleId IdType="pubmed">19187267</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasiene J., Komine O., Fujimori-Tonou N., Powers B., Endo F., Watanabe S., Shijie J., Ravits J., Horner P., Misawa H., et al. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Acta Neuropathol. Commun. 2016;4:15. doi: 10.1186/s40478-016-0286-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0286-7</ArticleId><ArticleId IdType="pmc">PMC4758105</ArticleId><ArticleId IdType="pubmed">26891847</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipchuk A.A., Durand J. Postnatal dendritic development in lumbar motoneurons in mutant superoxide dismutase 1 mouse model of amyotrophic lateral sclerosis. Neuroscience. 2012;209:144&#x2013;154. doi: 10.1016/j.neuroscience.2012.01.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.01.046</ArticleId><ArticleId IdType="pubmed">22387111</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A., Heath P.R., Holden H., Kasher P., Bender F.L.P., Claes F., Lambrechts D., Sendtner M., Carmeliet P., Shaw P.J. Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis. BMC Genom. 2010;11:203. doi: 10.1186/1471-2164-11-203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-11-203</ArticleId><ArticleId IdType="pmc">PMC2861063</ArticleId><ArticleId IdType="pubmed">20346106</ArticleId></ArticleIdList></Reference><Reference><Citation>Juan L., Dawei Z., Julie A.D. Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1(G93A) (G1H) transgenic mouse model of amyotrophic lateral sclerosis. Neurol. Res. 2007;29:204&#x2013;209. doi: 10.1179/174313206X152519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/174313206X152519</ArticleId><ArticleId IdType="pubmed">17439705</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Gulisano M. Involvement of brain-derived neurotrophic factor and sonic hedgehog in the spinal cord plasticity after neurotoxic partial removal of lumbar motoneurons. Neurosci. Res. 2012;73:238&#x2013;247. doi: 10.1016/j.neures.2012.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2012.04.010</ArticleId><ArticleId IdType="pubmed">22579680</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Gulisano M. Noggin and Sonic hedgehog are involved in compensatory changes within the motoneuron-depleted mouse spinal cord. J. Neurol. Sci. 2013;332:102&#x2013;109. doi: 10.1016/j.jns.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.06.029</ArticleId><ArticleId IdType="pubmed">23859181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Parenti R., Gulisano M. Novel mechanisms of spinal cord plasticity in a mouse model of motoneuron disease. Biomed. Res. Int. 2015;2015:654637. doi: 10.1155/2015/654637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/654637</ArticleId><ArticleId IdType="pmc">PMC4433663</ArticleId><ArticleId IdType="pubmed">26064939</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkowski L.F., Craig T.A., Stricklin O.E., Johnson K.A., Nichols N.L. 5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A) Respir. Physiol. Neurobiol. 2020;279:103471. doi: 10.1016/j.resp.2020.103471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2020.103471</ArticleId><ArticleId IdType="pmc">PMC7384973</ArticleId><ArticleId IdType="pubmed">32504811</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols N.L., Satriotomo I., Harrigan D.J., Mitchell G.S. Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS. Exp. Neurol. 2015;273:138&#x2013;150. doi: 10.1016/j.expneurol.2015.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.08.011</ArticleId><ArticleId IdType="pmc">PMC4644466</ArticleId><ArticleId IdType="pubmed">26287750</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;st B.M., Copray J.C.V.M., Brouwer N., Troost D., Boddeke H.W.G.M. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp. Neurol. 2002;177:419&#x2013;427. doi: 10.1006/exnr.2002.8011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2002.8011</ArticleId><ArticleId IdType="pubmed">12429188</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Narai H., Manabe Y., Nagai M., Nagano I., Ohta Y., Murakami T., Takehisa Y., Kamiya T., Abe K. Early detachment of neuromuscular junction proteins in ALS mice with SODG93A mutation. Neurol. Int. 2009;1:e16. doi: 10.4081/ni.2009.e16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ni.2009.e16</ArticleId><ArticleId IdType="pmc">PMC3093225</ArticleId><ArticleId IdType="pubmed">21577353</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S., Ferr&#xe3;o Santos A., Saxena S., Xu L., Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006;9:408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay E., Martineau E., Robitaille R. Opposite synaptic alterations at the neuromuscular junction in an ALS mouse model: When motor units matter. J. Neurosci. 2017;37:8901&#x2013;8918. doi: 10.1523/JNEUROSCI.3090-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3090-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596800</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp. Neurol. 2007;203:457&#x2013;471. doi: 10.1016/j.expneurol.2006.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.08.028</ArticleId><ArticleId IdType="pubmed">17034790</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr B.O., Hauswirth A.G., Celona B., Fetter R.D., Zunino G., Kvon E.Z., Zhu Y., Pennacchio L.A., Black B.L., Davis G.W. Presynaptic homeostasis opposes disease progression in mouse models of ALS-like degeneration: Evidence for homeostatic neuroprotection. Neuron. 2020;107:95&#x2013;111.e6. doi: 10.1016/j.neuron.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7529479</ArticleId><ArticleId IdType="pubmed">32380032</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Klima R., Buratti E., Verstreken P., Baralle F.E., Feiguin F. Chronological requirements of TDP-43 function in synaptic organization and locomotive control. Neurobiol. Dis. 2014;71:95&#x2013;109. doi: 10.1016/j.nbd.2014.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.07.007</ArticleId><ArticleId IdType="pubmed">25088713</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S., Han Y., Das A., Dickman D. Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration. Hum. Mol. Genet. 2017;26:4153&#x2013;4167. doi: 10.1093/hmg/ddx304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx304</ArticleId><ArticleId IdType="pmc">PMC5886083</ArticleId><ArticleId IdType="pubmed">28973139</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelon P.A., Dutchak P.A., Sephton C.F. Synaptic dysfunction in ALS and FTD: Anatomical and molecular changes provide insights into mechanisms of disease. Front. Mol. Neurosci. 2022;15:1000183. doi: 10.3389/fnmol.2022.1000183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2022.1000183</ArticleId><ArticleId IdType="pmc">PMC9575515</ArticleId><ArticleId IdType="pubmed">36263379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Lumi Nishimura A., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Machamer J.B., Woolums B.M., Fuller G.G., Lloyd T.E. FUS causes synaptic hyperexcitability in Drosophila dendritic arborization neurons. Brain Res. 2018;1693:55&#x2013;66. doi: 10.1016/j.brainres.2018.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.03.037</ArticleId><ArticleId IdType="pmc">PMC6347466</ArticleId><ArticleId IdType="pubmed">29625118</ArticleId></ArticleIdList></Reference><Reference><Citation>De Leo G., Gulino R., Coradazzi M., Leanza G. Acetylcholine and noradrenaline differentially regulate hippocampus-dependent spatial learning and memory. Brain Commun. 2022;5:fcac338. doi: 10.1093/braincomms/fcac338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac338</ArticleId><ArticleId IdType="pmc">PMC9825812</ArticleId><ArticleId IdType="pubmed">36632183</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Kostenko A., de Leo G., Emmi S.A., Nunziata D., Leanza G. Hippocampal noradrenaline regulates spatial working memory in the rat. In: Vardjan N., Zorec R., editors. Noradrenaline Signaling and Astroglia. 1st ed. Academic Press; Oxford, UK: 2017. pp. 201&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-805088-0.00010-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintus R., Riggi M., Cannarozzo C., Valeri A., de Leo G., Romano M., Gulino R., Leanza G. Essential role of hippocampal noradrenaline in the regulation of spatial working memory and TDP-43 tissue pathology. J. Comp. Neurol. 2018;526:1131&#x2013;1147. doi: 10.1002/cne.24397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24397</ArticleId><ArticleId IdType="pubmed">29355945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Fu A.K.Y., Ip N.Y. Instructive roles of astrocytes in hippocampal synaptic plasticity: Neuronal activity-dependent regulatory mechanisms. FEBS J. 2022;289:2202&#x2013;2218. doi: 10.1111/febs.15878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15878</ArticleId><ArticleId IdType="pmc">PMC9290076</ArticleId><ArticleId IdType="pubmed">33864430</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerasinghe-Mudiyanselage P.D.E., Ang M.J., Kang S., Kim J.-S., Moon C. Structural plasticity of the hippocampus in neurodegenerative diseases. Int. J. Mol. Sci. 2022;23:3349. doi: 10.3390/ijms23063349.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23063349</ArticleId><ArticleId IdType="pmc">PMC8955928</ArticleId><ArticleId IdType="pubmed">35328770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pletnikova O., Sloane K.L., Renton A.E., Traynor B.J., Crain B.J., Reid T., Zu T., Ranum L.P.W., Troncoso J.C., Rabins P.V., et al. Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging. 2014;35:2419.e17&#x2013;2419.e21. doi: 10.1016/j.neurobiolaging.2014.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.009</ArticleId><ArticleId IdType="pmc">PMC4087047</ArticleId><ArticleId IdType="pubmed">24819148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung G.-Y.R., DeJesus-Hernandez M., Feldman H.H., Sengdy P., Bouchard-Kerr P., Dwosh E., Butler R., Leung B., Fok A., Rutherford N.J., et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain. 2012;135:709&#x2013;722. doi: 10.1093/brain/awr354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr354</ArticleId><ArticleId IdType="pmc">PMC3286328</ArticleId><ArticleId IdType="pubmed">22344582</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Guo Z., Zhou B. Insight into the role of adult hippocampal neurogenesis in aging and Alzheimer&#x2019;s disease. Ageing Res. Rev. 2023;84:101828. doi: 10.1016/j.arr.2022.101828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101828</ArticleId><ArticleId IdType="pubmed">36549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson P.S., Perfilieva E., Bj&#xf6;rk-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage H.H. Neurogenesis in the adult human hippocampus. Nat. Med. 1998;4:1313&#x2013;1317. doi: 10.1038/3305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/3305</ArticleId><ArticleId IdType="pubmed">9809557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A.S., Sahay A., Hen R. Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors. Neuropsychopharmacology. 2015;40:2368&#x2013;2378. doi: 10.1038/npp.2015.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2015.85</ArticleId><ArticleId IdType="pmc">PMC4538351</ArticleId><ArticleId IdType="pubmed">25833129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Bonifacino T., Bartolucci M., Milanese M., Gallia E., Provenzano F., Cortese K., Panfoli I., Bonanno G. Characterization of the mitochondrial aerobic metabolism in the pre- and perisynaptic districts of the SOD1G93A mouse model of amyotrophic lateral sclerosis. Mol. Neurobiol. 2018;55:9220&#x2013;9233. doi: 10.1007/s12035-018-1059-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1059-z</ArticleId><ArticleId IdType="pubmed">29656361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis-L&#xf3;pez de Carrizosa M.A., Morado-D&#xed;az C.J., Morcuende S., de la Cruz R.R., Pastor A.M. Nerve growth factor regulates the firing patterns and synaptic composition of motoneurons. J. Neurosci. 2010;30:8308&#x2013;8319. doi: 10.1523/JNEUROSCI.0719-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0719-10.2010</ArticleId><ArticleId IdType="pmc">PMC6634574</ArticleId><ArticleId IdType="pubmed">20554882</ArticleId></ArticleIdList></Reference><Reference><Citation>Just-Borr&#xe0;s L., Cilleros-Ma&#xf1;&#xe9; V., Polishchuk A., Balany&#xe0;-Segura M., Tom&#xe0;s M., Garcia N., Tom&#xe0;s J., Lanuza M.A. TrkB signaling is correlated with muscular fatigue resistance and less vulnerability to neurodegeneration. Front. Mol. Neurosci. 2022;15:1069940. doi: 10.3389/fnmol.2022.1069940.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2022.1069940</ArticleId><ArticleId IdType="pmc">PMC9813967</ArticleId><ArticleId IdType="pubmed">36618825</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Hucha S., Carrero-Rojas G., Fern&#xe1;ndez de Sevilla M.E., Ben&#xed;tez-Temi&#xf1;o B., Davis-L&#xf3;pez de Carrizosa M.A., Pastor A.M., Morcuende S. Sources and lesion-induced changes of VEGF expression in brainstem motoneurons. Brain Struct. Funct. 2020;225:1033&#x2013;1053. doi: 10.1007/s00429-020-02057-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-020-02057-y</ArticleId><ArticleId IdType="pubmed">32189115</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E.B., De Winter F., Verhaagen J. ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter F., Vo T., Stam F.J., Wisman L.A.B., B&#xe4;r P.R., Niclou S.P., van Muiswinkel F.L., Verhaagen J. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol. Cell. Neurosci. 2006;32:102&#x2013;117. doi: 10.1016/j.mcn.2006.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2006.03.002</ArticleId><ArticleId IdType="pubmed">16677822</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchen L.W. Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: Differences between fast and slow muscles. J. Neurol. Neurosurg. Psychiatry. 1970;33:40&#x2013;54. doi: 10.1136/jnnp.33.1.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.33.1.40</ArticleId><ArticleId IdType="pmc">PMC493406</ArticleId><ArticleId IdType="pubmed">4907278</ArticleId></ArticleIdList></Reference><Reference><Citation>Balice-Gordon R.J. Dynamic roles at the neuromuscular junction. Schwann cells. Curr. Biol. 1996;6:1054&#x2013;1056. doi: 10.1016/S0960-9822(02)70662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(02)70662-3</ArticleId><ArticleId IdType="pubmed">8805358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko C.-P., Robitaille R. Perisynaptic Schwann cells at the neuromuscular synapse: Adaptable, multitasking glial cells. Cold Spring Harb. Perspect. Biol. 2015;7:a020503. doi: 10.1101/cshperspect.a020503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020503</ArticleId><ArticleId IdType="pmc">PMC4588062</ArticleId><ArticleId IdType="pubmed">26430218</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gonzalez A.P., Provost F., Rousse I., Piovesana R., Benzina O., Darabid H., Lamoureux B., Wang Y.S., Arbour D., Robitaille R. Functional adaptation of glial cells at neuromuscular junctions in response to injury. Glia. 2022;70:1605&#x2013;1629. doi: 10.1002/glia.24184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24184</ArticleId><ArticleId IdType="pmc">PMC9543218</ArticleId><ArticleId IdType="pubmed">35474470</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi H., Belluardo N., Arenas E., Yamamoto Y., Casabona A., Persson H., Ib&#xe1;&#xf1;ez C.F. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science. 1995;268:1495&#x2013;1499. doi: 10.1126/science.7770776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7770776</ArticleId><ArticleId IdType="pubmed">7770776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez M., Collins W.F., 3rd Modulation of motoneuron excitability by brain-derived neurotrophic factor. J. Neurophysiol. 1997;77:502&#x2013;506. doi: 10.1152/jn.1997.77.1.502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1997.77.1.502</ArticleId><ArticleId IdType="pubmed">9120591</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister A.K., Katz L.C., Lo D.C. Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 1999;22:295&#x2013;318. doi: 10.1146/annurev.neuro.22.1.295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.22.1.295</ArticleId><ArticleId IdType="pubmed">10202541</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez V., Bermedo-Garcia F., Zelada D., Court F.A., P&#xe9;rez M.A., Fuenzalida M., &#xc1;brigo J., Cabello-Verrugio C., Moya-Alvarado G., Tapia J.C., et al. The p75NTR neurotrophin receptor is required to organize the mature neuromuscular synapse by regulating synaptic vesicle availability. Acta Neuropathol. Commun. 2019;7:147. doi: 10.1186/s40478-019-0802-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0802-7</ArticleId><ArticleId IdType="pmc">PMC6739937</ArticleId><ArticleId IdType="pubmed">31514753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwick M., Teng L., Mu X., Springer J.E., Davis B.M. Overexpression of GDNF induces and maintains hyperinnervation of muscle fibers and multiple end-plate formation. Exp. Neurol. 2001;171:342&#x2013;350. doi: 10.1006/exnr.2001.7753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2001.7753</ArticleId><ArticleId IdType="pubmed">11573987</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Cruz R.R., Pastor A.M., Delgado-Garc&#xed;a J.M. Influence of the postsynaptic target on the functional properties of neurons in the adult mammalian central nervous system. Rev. Neurosci. 1996;7:115&#x2013;149. doi: 10.1515/REVNEURO.1996.7.2.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/REVNEURO.1996.7.2.115</ArticleId><ArticleId IdType="pubmed">8819206</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochat C., Bernard-Marissal N., K&#xe4;llstig E., Pradervand S., Perrin F.E., Aebischer P., Raoul C., Schneider B.L. Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis. Glia. 2022;70:842&#x2013;857. doi: 10.1002/glia.24140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24140</ArticleId><ArticleId IdType="pmc">PMC9303637</ArticleId><ArticleId IdType="pubmed">34978340</ArticleId></ArticleIdList></Reference><Reference><Citation>Blizzard C.A., Southam K.A., Dawkins E., Lewis K.E., King A.E., Clark J.A., Dickson T.A. Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis&#x2014;Vulnerability of lower motor neurons to proximal excitotoxicity. Dis. Model. Mech. 2015;8:215&#x2013;224. doi: 10.1242/dmm.018606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.018606</ArticleId><ArticleId IdType="pmc">PMC4348560</ArticleId><ArticleId IdType="pubmed">25740331</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M.L., Bourefis A.R., Kabashi E. Diagnostic challenge and neuromuscular junction contribution to ALS pathogenesis. Front. Neurol. 2019;10:68. doi: 10.3389/fneur.2019.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00068</ArticleId><ArticleId IdType="pmc">PMC6372519</ArticleId><ArticleId IdType="pubmed">30787905</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman M.P. Axon biology in ALS: Mechanisms of axon degeneration and prospects for therapy. Neurotherapeutics. 2022;19:1133&#x2013;1144. doi: 10.1007/s13311-022-01297-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01297-6</ArticleId><ArticleId IdType="pmc">PMC9587191</ArticleId><ArticleId IdType="pubmed">36207571</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A. The dying forward hypothesis of ALS: Tracing its history. Brain Sci. 2021;11:300. doi: 10.3390/brainsci11030300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030300</ArticleId><ArticleId IdType="pmc">PMC7997258</ArticleId><ArticleId IdType="pubmed">33673524</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer A.K., Jones K.J., Sanders V.M., Walker C.L. Temporospatial analysis and new players in the immunology of amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2018;19:631. doi: 10.3390/ijms19020631.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19020631</ArticleId><ArticleId IdType="pmc">PMC5855853</ArticleId><ArticleId IdType="pubmed">29473876</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;pine S., Castellanos-Montiel M.J., Durcan T.M. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis. Transl. Neurodegener. 2022;11:56. doi: 10.1186/s40035-022-00331-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00331-z</ArticleId><ArticleId IdType="pmc">PMC9793560</ArticleId><ArticleId IdType="pubmed">36575535</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S., Khurana S., Vats A., Sahu B., Ganguly N.K., Chakraborti P., Gourie-Devi M., Taneja V. Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol. Neurobiol. 2022;59:1502&#x2013;1527. doi: 10.1007/s12035-021-02658-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02658-6</ArticleId><ArticleId IdType="pubmed">34997540</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgerton V.R., Tillakaratne N.J.K., Bigbee A.J., de Leon R.D., Roy R.R. Plasticity of the spinal neural circuitry after injury. Annu. Rev. Neurosci. 2004;27:145&#x2013;167. doi: 10.1146/annurev.neuro.27.070203.144308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144308</ArticleId><ArticleId IdType="pubmed">15217329</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Dimartino M., Casabona A., Lombardo S.A., Perciavalle V. Synaptic plasticity modulates the spontaneous recovery of locomotion after spinal cord hemisection. Neurosci. Res. 2007;57:148&#x2013;156. doi: 10.1016/j.neures.2006.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2006.10.001</ArticleId><ArticleId IdType="pubmed">17083989</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Lombardo S.A., Casabona A., Leanza G., Perciavalle V. Levels of brain-derived neurotrophic factor and neurotrophin-4 in lumbar motoneurons after low-thoracic spinal cord hemisection. Brain Res. 2004;1013:174&#x2013;181. doi: 10.1016/j.brainres.2004.03.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.03.055</ArticleId><ArticleId IdType="pubmed">15193526</ArticleId></ArticleIdList></Reference><Reference><Citation>Raineteau O., Schwab M.E. Plasticity of motor systems after incomplete spinal cord injury. Nat. Rev. Neurosci. 2001;2:263&#x2013;273. doi: 10.1038/35067570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35067570</ArticleId><ArticleId IdType="pubmed">11283749</ArticleId></ArticleIdList></Reference><Reference><Citation>Samejima S., Henderson R., Pradarelli J., Mondello S.E., Moritz C.T. Activity-dependent plasticity and spinal cord stimulation for motor recovery following spinal cord injury. Exp. Neurol. 2022;357:114178. doi: 10.1016/j.expneurol.2022.114178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2022.114178</ArticleId><ArticleId IdType="pubmed">35878817</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolpaw J.R., Tennissen A.M. Activity-dependent spinal cord plasticity in health and disease. Annu. Rev. Neurosci. 2001;24:807&#x2013;843. doi: 10.1146/annurev.neuro.24.1.807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.24.1.807</ArticleId><ArticleId IdType="pubmed">11520919</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>